Abstract

Anemia, a prevalent hematologic manifestation in individuals living with Human
Immunodeficiency Virus (HIV) infection, has garnered considerable attention as a prognostic
indicator for disease progression and adverse clinical outcomes. This abstract presents a
comprehensive review elucidating the intricate relationship between anemia and the
progression of HIV infection, incorporating epidemiological trends, underlying
pathophysiological mechanisms, clinical implications, and prognostic significance. Despite
advances in antiretroviral therapy (ART), anemia remains a frequent complication in HIVinfected
individuals, posing substantial challenges to patient management. This paper aims
to provide a nuanced understanding of anemia's role as a prognostic marker, surpassing its
conventional characterization as a hematologic abnormality in the context of HIV infection.
Anemia's role as a predictive marker for adverse clinical outcomes in HIV patients is
explored, encompassing increased mortality rates, heightened risk of opportunistic
infections, accelerated disease progression, and compromised quality of life. The review
delves into its prognostic significance, shaping therapeutic decisions and prognostic
assessments. This paper encapsulates the criticality of anemia as a prognostic marker for
disease progression in HIV infection. Understanding its epidemiology, pathophysiological
mechanisms, clinical implications, and prognostic significance is pivotal for informed
clinical decision-making, prognostic assessments, and optimizing care paradigms in HIV
management.
Keywords: Anemia, Prognostic Marker, Disease Progression and HIV